Improving Mesothelioma Survival by Targeting New Genetic Mutations

Research from Brigham and Women’s Cancer Center in Boston recently identified a distinct spectrum of genetic mutations in pleural mesothelioma tumors, a blockbuster finding that should significantly improve future treatment of the disease. It was the breakthrough the mesothelioma community was anticipating. “This is probably the most significant advancement in the treatment of mesothelioma since the advent of cytoreductive surgery,” thoracic surgeon Dr. David Sugarbaker, director of the Lung Institute at Baylor College of Medicine and America’s foremost authority on pleural mesothelioma, told Asbestos.com. “This is very exciting. It could mean long-term survival is a reality for a large number of patients.” Sugarbaker co-authored the research study published this month...

from MedWorm: Mesothelioma http://medworm.com/index.php?rid=169676341&cid=c_409_55_f&fid=36962&url=http%3A%2F%2Fwww.asbestos.com%2Fnews%2F2016%2F03%2F10%2Fimprove-mesothelioma-survival-target-genetic-mutations%2F